Skip to cookie consent Skip to main content

Michael Greeley

General Partner, Flare Capital Partners

Michael Greeley is a co-founder and general partner at Flare Capital Partners. Previously, Michael was the founding general partner of Flybridge Capital Partners, and, earlier in his career, he was with Polaris Partners. He also held positions at Wasserstein Perella & Co. and Morgan Stanley & Co.


His current and prior board seats include Aspen RxHealth, Author Health, Axuall, BlueTarp Financial, Cayaba Care, Circulation, Cohere Health, Explorys, Functional Neuromodulation, HealthVerity, higi, Inbound Health, Iora Health, MicroCHIPS, Nuvesse, Oshi Health, PolyRemedy, Predictive Biosciences, Predilytics, RightMove Health, T2 Biosystems, TARIS Biomedical, VidSys, and Welltok (observer). Additionally, Michael has served on the board of International Data Group, the founding partner of IDG Capital, a leading venture capital fund in China and other important innovation centers in Asia, and is on the board of The Forsyth Institute, the leading Harvard-affiliated oral health research organization.


He serves on various innovation and investment advisory boards for Advocate Aurora Health, Boston Children’s Hospital, Cleveland Clinic, and MedStar Health, as well as serving on the Governor’s Digital Health Council and the Massachusetts Technology Collaborative. Michael also serves on the investment committee for the Mass General Brigham Innovation Fund and on is the advisory board of Harvard Business School’s Health Care Initiative. He was past chairman of the New England Venture Capital Association and on the board and executive committee of the National Venture Capital Association. Michael earned a BA with honors in chemistry from Williams College and an MBA from Harvard Business School.


He authors a blog focused on venture capital, innovation, and health care.